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Epithelial cells of the thymus cortex express a unique
proteasome particle involved in positive T cell selec-
tion. This thymoproteasome contains the recently
discovered b5t subunit that has an uncharted
activity, if any. We synthesized fluorescent epoxomi-
cin probes that were used in a chemical proteomics
approach, entailing activity-based profiling, affinity
purification, and LC-MS identification, to demon-
strate that the b5t subunit is catalytically active in
the murine thymus. A panel of established protea-
some inhibitors showed that the broad-spectrum
inhibitor epoxomicin blocks the b5t activity and
that the subunit-specific antagonists bortezomib
and NC005 do not inhibit b5t. We show that b5t has
a substrate preference distinct from b5/b5i that
might explain how the thymoproteasome generates
the MHC class I peptide repertoire needed for posi-
tive T cell selection.
INTRODUCTION
The ability to recognize nonself oligopeptides is a key feature of
mammalian immunity. T cells that recognize antigenic oligopep-
tides elicit a directed adaptive immune response aimed at the
identification and eventual eradication of the invading pathogen
that is the source of the nonself protein from which the antigenic
oligopeptide is derived (Janeway and Bottomly, 1994; Medzhi-
tov, 2007). T cell recognition is effected by binding of specific
T cell receptors to the antigenic peptides that are complexed
to either major hisocompatibility complex (MHC) class I or
MHC class II molecules (Huseby et al., 2005; Takahama et al.,
2008). MHC I molecules present oligopeptides derived from
cytosolic and nuclear proteins to CD8+ cytotoxic T lymphocytes
(CTL) and by this virtue report on the presence of virally encoded
proteins (Kloetzel and Ossendorp, 2004). T cells specific forChemistry & Biology 17, 79nonself peptides are produced by thymic selection. The genera-
tion in the thymus of nonself peptide-selective CTL proceeds in
two discreet events (Nitta et al., 2008). Positive selection ismedi-
ated by cortical thymic epithelial cells. In this process, thymo-
cytes expressing T cell receptors are confronted with tissues
expressing MHC I molecules loaded with oligopeptides. Current
understanding is that the MHC I/peptide antigen complexes
produced by cortical thymic epithelial cells are low-affinity
T cell receptor binders. Thymocytes passing through the thymic
cortex that bind to MHC I molecules carrying a peptide load are
selected from thymocytes expressing nonbinding receptors. In
the ensuing negative selection step, mediated by medullary
thymic epithelial cells, thymocytes from the positively selected
pool that are responsive to MHC I molecules exposing self-
peptides are eliminated.
Recently, Tanaka and co-workers made a major breakthrough
toward understanding how positive selection proceeds (Murata
et al., 2007). They found that epithelial cells at the thymic cortex
express, next to the constitutive proteasome and the immuno-
proteasome, a third 20S proteasome particle which was dubbed
the thymoproteasome. The 20S core particle of the proteasome
is assembled from a and b subunits in a pattern of four, stacked,
heptameric rings (a1-7, b1-7, b1-7, a1-7) generating a barrel-
shaped structure that contains two copies of the catalytically
active b subunits: b1 (post acidic), b2 (tryptic-like), b5 (chymo-
triptic-like) peptidase activities (Baumeister et al., 1998). The
thymoproteasome contains the b1i and b2i subunits just like
the immunoproteasome, with the important exception that the
unique subunit b5t replaces the immunoproteasome-specific
subunit, b5i.
The thymoproteasome is the most abundant proteasome
species in cortical thymic epithelial cells (cTEC). Thymoprotea-
some expression may have implications for the repertoire of
oligopeptides presented by MHC I molecules on the surface of
cTECs that might significantly differ from to the repertoire
produced by medullary thymic epithelial cells. Closer inspection
of the thymoproteasome 20S particle revealed that, in contrast
to the constitutive and the immunoproteasome, it possessed
little chymotryptic activity, a finding that seems to correlate5–801, August 27, 2010 ª2010 Elsevier Ltd All rights reserved 795
Figure 1. Activity-Based Probes and Proteasome Inhibitors Used in This Study
In addition to the enzyme reactive group (warhead) and targeting sequence of the inhibitors, activity-based probes are equipped with a fluorophore for in-gel
detection, a biotin tag for affinity purification or with both.
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of b5t compared with b5/b5i (Murata et al., 2007). In theory, b5t
can contribute in two ways to the generation of specific MHC I
peptides used in positive T cell selection (Murata et al., 2008).
It could act as an impassive, catalytically inactive bystander, in
which case b1i/b2i produces the majority of MHC I peptides
with a bias toward their substrate preferences. Alternatively, it
could actively participate in protein degradation and assist in
producing ‘‘nonself’’ peptides thanks to its intrinsic substrate
preference, which then must be distinct from that of b5/b5i.
Activity-based probes are synthetic compounds bearing
a reporter or affinity tag and an enzyme reactive group that can
covalently bind to the active site of an enzyme (Cravatt et al.,
2008). The tagged enzymatic activities can than be visualized
by fluorescence or affinity purified, digested with trypsin, and
identified by LC/MS analysis. We here demonstrate, by making
use of activity-based proteasome probes (Verdoes et al.,
2009), that b5t is in fact a catalytically active subunit and show
that its preference toward established proteasome inhibitors
differs substantially from those of b5/b5i.796 Chemistry & Biology 17, 795–801, August 27, 2010 ª2010 ElseviRESULTS AND DISCUSSION
Activity-Based Profiling Reveals b5t Activity
As the first experiment, we incubated whole tissue thymus
homogenate from 3-week-old mice with the fluorescent broad-
spectrum ABPs 1, (Verdoes et al., 2008) 2, 4, and MV151
(Verdoes et al., 2006) shown in Figure 1 (for the synthesis of
probes 2 and 4, see Supplemental Experimental Procedures
available online). Proteins were resolved by SDS-PAGE under
reducing conditions and fluorescently labeled proteasome
subunits were visualized by in-gel fluorescence scanning. In
Figure 2A, MV151 shows the typical band pattern of staining
that is similar to that of the EL4 cell line expressing the constitu-
tive and the immunoproteasome (Kessler et al., 2001) (Figure S1)
indicating that both particles are expressed in the thymus.
Peptide vinyl sulphone 1, the biotinylated derivative of MV151,
shows a similar pattern as MV151. Interestingly, the peptide
epoxyketones 2 and 4 show two new bands that run below
and above the constitutive and immunoproteasome subunits.
Of these, the lower band corresponds to b1i.er Ltd All rights reserved
Figure 2. Activity-Based Profiling, Affinity Purification, and LC-MS
Identification of Proteasome b Subunits in Murine Tissues Lysates
(A) In-gel fluorescence detection of active proteasome b subunits in 3-week-
old wild-type murine thymus homogenate after labeling with MV151, ABP 1,
2, and 4 (see also Figure S1). M indicates themolecular marker band of 25 kDa.
(B) In-gel fluorescence and silver stain detection of active proteasome
b subunits in young and adult thymus after labeling with ABP 1, 2, 3, and affinity
purification. Protein identification by LC-MS analysis of in-gel digested silver-
stained bands (see Tables S1 and S2 for details).
(C) In-gel fluorescence detection with ABP 4 of b5t activity in wild-type and
absence of activity in the (/) b5t knockdown thymus from 3-weeks-old
mice.
(D) Activity-based proteasome profiling using ABP 4 shows b5t activity in
murine thymus (young and adult) but not in heart, lung, liver, spleen, brain,
testes, or kidney.
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with a gel mobility corresponding to the predicted molecular
weight of b5t (Murata et al., 2007), is indeed b5t and not
a thymus-specific gene product unrelated to the thymoprotea-
some, we performed a pull-down experiment by making use of
the biotin moiety present in ABPs 1 and 2. Biotinylated proteins
from thymus homogenate were captured by streptavidin-coated
magnetic beads, resolved by SDS-PAGE and detected both by
fluorescence and silver staining. Figure 2B shows the specific
purification of several proteins that run in a pattern similar with
that of Figure 2A. Protein ID, indicated by arrows in Figure 2B,
was determined by on-bead (Table S2) and in-gel tryptic diges-
tion followed by LC-MS/MS analysis. Oligopeptides corre-
sponding to the expected constitutive proteasome (b1/b2/b5)
and immunoproteasome (b1i/b2i/b5i) were captured by ABP 1
but no evidence for b5t was found. Peptides derived from b5t
were found by affinity purification with ABP 2, indeed in the
band running higher than the other active b subunits. However,Chemistry & Biology 17, 79the protein yield achieved by pull-down with ABP 1 and 2 was
low, and we hypothesized that the short biotinylated epoxomicin
ABP 3 might increase the pull-down efficiency (for the synthesis
of probe 3, see Supplemental Experimental Procedures). ABP 3
performed as expected, showing bands of similar pattern as
ABP 2, stronger signal in silver-stained gels and reliable LC-
MS identification of proteins (Table S1). Thymus from adult
animals treated in the same fashion shows b5t activity as well,
which suggests that the murine thymoproteasome remains
active for at least 6 months. Next to the active proteasome
b subunits, only four endogenously biotinylated background
proteins were recovered with this method, a result that reflects
the selectivity of ABPs 1, 2, 3, and 4 toward proteasomes.
Thymus lysates of 2-week-old mice in which the b5t protein
expression was genetically knocked down show normal activity
of immuno- and constitutive proteasome compared with the
wild-type, but complete absence of b5t activity (Figure 2C). To
characterize the expression of b5t in murine tissues, we per-
formed a tissue scan with ABP probe 4. Figure 2D shows that
b5t activity is exclusively present in the young thymus and at
lower activity in thymus of 6-month-old mice. Integration of the
fluorescent signal from young thymus indicated that b5t contrib-
utes to some 4% of the total active signal in this full thymus
lysate. Heart, lung, liver, spleen, brain, testes, and kidney do
not show b5t activity. The presence of immunoproteasome
bands in the heart, lung, liver, and spleen tissues is explained
by the presence of lymphocytes in these organs.
LC-MS3 Analysis of the b5t Active-Site Peptide
Isolation and analysis of the active-site peptide covalently bound
to ABP probe 3 would be the ultimate proof for the b5t acitivity.
Biotin-epoxomicin binds to the catalytic N-terminal threonine via
an irreversiblemorpholino ring formation shown in Figure 3A. The
b5t active-site peptide (Figure 3B) is generated after denatur-
ation and tryptic digest of the thymoproteasome. Given that
biotin-epoxomicin binds to all active b subunits, we expect to
find six different active-site peptides because the tryptic
peptides derived from b5 and b5i are identical (see Table S3).
After LC-MS analysis, the active-site peptides were identified
from the high resolution full MS scans by their exact mass and
charge (Figure 3C). Further evidence was provided by the
MS/MS (MS2) fragmentation that revealed the presence of the
biotin-epoxomicin signature ions b1, b2, b3, and b4 from Fig-
ure 3D. In fact, the favored fragmentation of the morpholino
ring due to push-pull radical stabilization of the ions (Carey and
Sundberg, 2008) yields mainly two major ions b4 and y7, where
y7 contains the peptide sequence of the b subunit active-site.
By electrostatic trapping and further MS3 fragmentation of the
y7 ion, the LAFR sequence of the b5t active-site peptide was
identified (Figure 3E). Taken together, this data set demonstrates
that b5t is, indeed, a reactive proteasome subunit.
Competitive Activity-Based Profiling Reveals b5t
Substrate Specificity
The finding that b5t reacts with epoxyketones 2, 3, and 4, but not
with peptide vinyl sulphones 1 and MV151 gives a first indication
of an altered substrate specificity compared to b5/b5i. With
probe 4 in hand as readout, we set out to investigate the b5t
substrate preference by competitive activity-based studies5–801, August 27, 2010 ª2010 Elsevier Ltd All rights reserved 797
Figure 3. Active-Site Peptide Identification and Determination
of Proteasome b Subunits by Affinity Purification, Tryptic Digest,
and LC-MS Analysis
(A) Reaction mechanism of biotin-epoxomicin 3 with the catalytically active
N-terminal Thr residue of active proteasome b subunits. The morpholino ring
formation results in a covalent and irreversible binding.
(B) Schematic representation of the biotin-epoxomicin modified, N-terminal
active-site tryptic peptide of b5t. Amino acid residues are represented in
a three-letter code.
(C) LC-MS elution profile of the six unique biotinylated tryptic peptides derived
from the active sites. Notice that b5 and b5i active-site peptides are identical
(see also Table S3).
(D) LC-MS2 determination of the b5t active-site fragmentation pattern. The
parent ion [m/z (M+2H)2+ = 767.44] was fragmented. The b1, b2, b3, and b4
ions are signature ions of the biotin-epoxomicin N-terminal part. The abundant
y7 ion containing the b5t active-site peptide sequence was selected for further
(MS3) fragmentation (see E).
(E) LC-MS3 determination of the y7 ion (MH
+ = 821.32) revealing the b5t active-
site peptide amino acid sequence.
Figure 4. Analysis of b5t Substrate Specificity in Juvenile Murine
Thymus Lysates by Competitive Activity-Based Profiling with ABP 4
(A) Lysates were exposed to increasing concentrations Lactacystin or MG132;
residual b5t activity was stained with ABP 4 and visualized by in-gel fluores-
cence detection. The inhibitors are not reactive toward the b5t activity.
(B) Bortezomib efficiently inhibits b5, b5i, b1, and b1i activity but not b5t.
NC005 specifically targets b5 (indicated by the gray arrow) but not b5t.
The mixed inhibitor containing the boronic ester warhead equipped with the
epoxomicin tail efficiently blocks b5t.
(C) In analogy to (B), installation of the epoxomicin IleIleThrLeu peptide target-
ing motif to the vinyl sulphone warhead affords a potent inhibitor of the b5t
activity.
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798 Chemistry & Biology 17, 795–801, August 27, 2010 ª2010 Elseviwith established proteasome inhibitors of diverse chemical char-
acteristics. Figure 4A shows the results of the most commonly
used proteasome inhibitors lactacystin (Fenteany et al., 1995)
andMG132 (Rock and Goldberg, 1999). Both require concentra-
tions higher that 10 mM for broad-spectrum proteasome inhibi-
tion with marked affinity for b5 and b2 but do not inhibit the b5t
activity. Figure 4B shows that the Bortezomib boronic ester 5
effectively blocks b1, b1i, b5, and b5i as previously described
(Adams et al., 1998; Verdoes et al., 2007), while the subunit-
specific inhibitor NC005 (Britton et al., 2009) selectively inhibits
the b5/b5i subunits. Neither bortezomib nor NC005 appears
to interact with the b5t. However, mixing of the potent boronic
ester warhead with the AcI2TL peptide sequence inherent to
epoxomicin as in compound 13 abolished the subunit preference
of bortezomib and efficiently inhibited b5t. A similar effect is
revealed in Figure 4C where the vinyl sulphone warhead (Bogyo
et al., 1997) was equipped with the AdaAhx3 extended I2TL
motif. Apparently, the presence of the hydrophilic threonine
side chain at P2 in an inhibitor or ABP probe is favorable for
affinity to the b5t subunit. From the results, some interesting
trends pointing toward a substrate preference of b5t that is rather
distinct to that of b5/b5i appear. Whereas b5t is sensitive toward
the broad-spectrum proteasome epoxomicin 6, it is quite
unreactive toward the b5/b5i-biased compounds. Bortezomib
boronic ester 5 (which at the concentrations used disables b1/
b1i/b5/b5i) and lactacystin 8 are unreactive toward b5t, as is
the case with vinyl sulfone 7, peptide aldehyde 9, and epoxyke-
tone 12.er Ltd All rights reserved
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b5t activity could be detected in fluorogenic substrate assays.
In a first experiment, lysates of 3-week-old wild-type and b5t/
murine thymi were preincubated with 1 mM 10, 6, 9, or the b5/b5i-
specific inhibitor NC005 (12) prior to treatment with the reported
b5-specific fluorogenic substrate, Ac-LLVY-amc (Kisselev and
Goldberg, 2005). No differential signal could be detected in the
wt versus the b5t/ lysates (data not shown), indicating that
this substrate does not react with b5t. We next synthesized two
novel fluorogenic substrates, Ac-IITL-amc and Ac-SSTL-amc
(Supplemental Experimental Procedures) that were expected
to be cleaved by all catalytically active b subunits, including
b5t. Preincubation of wild-type and b5t/ lysates with 1 mM
10, 6, 9, or 12 followed by b5t read-out with Ac-IITL-amc or
Ac-SSTL-amc again did not result in a discernible b5t-specific
signal (data not shown). We next fractionated the lysates by
10%–40% sucrose gradient ultracentrifugation and used the
enriched (thymo)proteasome fractions as determined by ABP
profiling with 4 (Figure S2). The tryptic- and caspase-like activi-
ties were inhibited with 1 or 10 mM 6 or 7 and the b5t activity
was assayed with Ac-IITL-amc or Ac-SSTL-amc (Figure S3).
Again, no differences could be found between wild-type and
b5t/ (thymo)proteasomes.
In conclusion, we have demonstrated that b5t has an intrinsic
reactivity resembling that of the other proteasome catalytic b5t
subunits and have obtained evidence suggesting that this
thymoproteasome-specificsubunit playsanactive role inpositive
T cell selection. Our discovery that b5t is an active species is
based on activity-based probes, and we acknowledge the fact
that the reactivegroupsdiffer in nature fromthenatural substrates
(vinyl sulphone/epoxyketone as opposed to amide bonds). We
note, however, that all known proteasome catalytic subunits are
active toward these electrophilic traps andmoreover that all non-
actives are not. In fact, we argue that activity-based enzyme
profiling is especially attractive for probing putative proteasome
active sites, which are active only in the context of the 20S
conglomerate as a whole and by activity-based profiling, can still
be reported on individually. We indeed were unable to detect b5t
activity by using fluorogenic substrates, due to the fact that the
substrates we were able to obtain or design based on our data
were either specific for b5/b5i (in which case no b5t activity is to
be expected based on our inhibition studies) or are pan-reactive
(in which case we could not discriminate between the different
activities). More research is required to identify a fluorogenic
substrate specific for b5t, and we argue this may be accom-
plished by screening (libraries of) designed inhibitors against
thymoproteasomes in an activity-based profiling assay such as
disclosed here. Altogether, our data, revealing that b5t is catalyt-
ically active toward inhibitors that contain a hydrophilic residue
(Thr) in a hydrophobic stretch, point toward the involvement of
b5t in the generation of a unique set of oligopeptides complexed
to MHC I molecules for optimal positive T cell selection.
SIGNIFICANCE
We demonstrate for the first time to the best of our knowl-
edge that thymoproteasome-specific b5t subunit is catalyt-
ically active. Interestingly, active b5t is also found in adult
thymi but not in other murine organs. We provide the firstChemistry & Biology 17, 79insight into the nature of the substrate preference of b5t
that is probably biased toward peptides with hydrophilic
side chains. This body of evidence was made possible
by the direct action of activity-based probes (ABP) with
emphasis on the bifunctional ABPs that facilitate both
readout and affinity purification. Moreover, the Bodipy-ep-
oxomicin probe shows superior labeling and SDS-PAGE
resolution for the active b subunits. The biotin-epoxomicin
probe facilitated the LC-MS3 identification of the b5t
active-site peptide that is the ultimate proof for the reactivity
of this subunit. This work illustrates the versatility of fluores-
cent activity-based probes and opens new avenues of
detection as fluorescence microscopy or flow cytometry in
living cells. Therefore, the probes presented here should
be considered as a powerful addition to the toolbox for pro-
teasome activity determination and quantification besides
the classic fluorogenic substrate assays.
EXPERIMENTAL PROCEDURES
Animals and Tissues
Thymus and other organs were isolated from young (3 week old) or adult mice
and kindly provided by Ine Tijdens, Chantal Pont, and Prof. Dr. Bob van de
Water. Thymus from b5t knockout mice was kindly provided by Dr. Keiji
Tanaka. Organ isolation was approved by the animal experimentation ethical
committee of the Leiden University and Tokyo Metropolitan Institute of
Medical Science.
Compounds
Design, synthesis, and mechanism of action of the activity-based probes 1–4,
MV151, and the proteasome inhibitors 5–11, 13 is reviewed in Verdoes et al.
(2009). NC005 is described in Britton et al. (2009). Lactacystin, MG132, and
all other compounds of analytical grade were purchased from Sigma-Aldrich.
Activity-Based Profiling
Tissues were homogenized in 3 volumes of ice-cold lysis buffer (50 mM Tris-
HCl [pH 7.5], 250 mM sucrose, 5 mM MgCl2, 1 mM DTT, 2 mM ATP,
0.025% digitonin, 0.2% NP40; Kisselev and Goldberg, 2005) with a tissue
homogenizer and further disrupted by 2 3 30 s sonication. Lysates were
cleared by cold centrifugation at 13,000 3 g, protein concentrations deter-
mined by Bradford assay and kept at 80C until use. For comparative
activity-based profiling, equal amounts of protein were incubated with ABPs
for 1 hr at 37C and resolved by 12.5% SDS-PAGE, and the wet gel slab
was scanned on a Thyphoon scanner (GEHealthcare) with the TAMRA settings
(lex = 530 nm, lem = 560 nm). Competitive activity-based profiling was done by
first incubating thymus lysates with increasing concentrations of various pro-
teasome inhibitors for 1 hr at 37C, followed by 1 hr incubation with 0.5 mM
ABP 4 for the in-gel detection of the residual proteasome activity. Images
were acquired, processed, and quantified with Image Quant (GE Healthcare).
Affinity Purification
Approximately 1 or 2 mg of protein was incubated with 10 mM biotinylated
ABPs 1, 2 or 3 for 1 hr at 37C, denatured by boiling for 5 min with 1% SDS
and precipitated with chloroform/ methanol (C/M, Wessel and Flu¨gge, 1984).
The protein pellet was rehydrated in 180 ml 8 M urea/100 mM NH4HCO3,
reduced with 10 ml 90 mM DTT for 30 min at 37C, alkylated with 15 ml
200 mM iodoacetamide at room temperature in the dark, cleared by centrifu-
gation at 13,000 3 g, and desalted by C/M. The pellet was dispersed in 25 ml
PD buffer (50 mM Tris-HCl [pH 7.5], 150 mM NaCl) with 2% SDS in a heated
(37C) sonic bath. Stepwise (3 3 25 ml, 4 3 100 ml, 1 3 500 ml) addition of
PD buffer afforded a clear solution that was incubated with 50 ml MyOne T1
Streptavidin-grafted beads (Invitrogen) at room temperature with vigorous
shaking for 2 hr. The beads were stringently washed with 23 300 ml PD buffer
with 0.1% SDS, 23 300 ml PD buffer, 23 300 ml wash buffer I (4 M urea/50 mM
NH4HCO3), 2 3 300 ml wash buffer II (50 mM Tris-HCl [pH 7.5], 10 mM NaCl),5–801, August 27, 2010 ª2010 Elsevier Ltd All rights reserved 799
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with 100 ml 13 sample buffer containing 10 mM biotin by boiling for 5 min at
90C and resolved by 12.5% SDS-PAGE. Proteins were visualized by fluores-
cence and silver stain, in-gel digested (Shevchenko et al., 2006), and desalted
(Rappsilber et al., 2007). For on/bead digest, one-third of the beads were
digested with 300 ng trypsin in 100 ml digest buffer (100 mM Tris-HCl
[pH 7.8], 100 mM NaCl, 1 mM CaCl2, 2% ACN) overnight at 37
C. Peptides
were collected and desalted on stage tips. The active-site peptides were
eluted with 2 3 80 ml 10 mM biotin in 5% formic acid/25% ACN/70% H2O for
30 min at 37C and desalted after ACN evaporation.
LC-MS Analysis
Trytic peptides were analyzed on a Surveyor nanoLC system (Thermo)
hyphenated to a LTQ-Orbitrap mass spectrometer (Thermo). Gold and carbon
coated emitters (OD/ID = 360/25 mm tip ID = 5 mm), trap column (OD/ID = 360/
100 mm packed with 25 mm robust Poros10R2/ 15 mm BioSphere C18 5 mm
120 A˚) and analytical columns (OD/ID = 360/75 mm packed with 20 cm
BioSphere C18 5 mm 120 A˚) were from Nanoseparations (Nieuwkoop, The
Netherlands). The mobile phases (A: 0.1% FA/H2O, B: 0.1% FA/ACN) were
made with ULC/MS grade solvents (Biosolve). The emitter tip was coupled
end-to-end with the analytical column via a 15 mm long TFE Teflon tubing
sleeve (OD/ID 0.3 3 1.58 mm, Supelco, USA) and installed in a stainless steel
holder mounted in a nano-source base (Upchurch scientific, Idex, USA).
General mass spectrometric conditions were as follows: an electrospray
voltage of 1.8 kV was applied to the emitter, no sheath and auxiliary gas
flow, ion transfer tube temperature 150C, capillary voltage 41 V, tube lens
voltage 150 V. Internal mass calibration was performed with air-borne proton-
ated polydimethylcyclosiloxane (m/z = 445.12002) and the plasticizer proton-
ated dioctyl phthalate ions (m/z = 391.28429) as lock mass (Olsen et al., 2005).
For shotgun proteomics analysis, 10 ml of the samples was pressure loaded
on the trap column with a 10 ml/min flow for 5 min followed by peptide separa-
tion with a gradient of 35min 5%–30%B, 15min 30%–60%B, 5min A at a flow
of 300 ml/min split to 250 nl/min by the LTQ divert valve. For each data-depen-
dent cycle, one full MS scan (300–2000 m/z) acquired at high mass resolution
(60,000 at 400 m/z, AGC target 1 3 106, maximum injection time 1000 ms) in
the Orbitrap was followed by three MS/MS fragmentations in the LTQ linear
ion trap (AGC target 5 3 103, maximum injection time 120 ms) from the three
most abundant ions (Baek et al., 2008). MS2 settings were as follows: collision
gas pressure 1.3 mT, normalized collision energy 35%, ion selection threshold
of 500 counts, activation q = 0.25 and activation time of 30 ms. Fragmented
precursor ions that were measured twice within 10 s were dynamically
excluded for 60 s and ions with z < 2 or unassigned were not analyzed.
A parent ion list of the m/z ratios of the active-site peptides was compiled
and used for LC-MS3 analysis in a data-dependent protocol. The parent ion
was electrostatically isolated in the ion trap of the LTQ and fragmented by
MS2, and the most intense peak was isolated and further fragmented in MS3
to reveal the amino acid sequence of the active-site peptide. Data from MS2
and MS3 were validated manually.
SUPPLEMENTAL INFORMATION
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